Setmelanotide: A Physician’s Read on MC4R Agonism, From POMC Deficiency to TRANSCEND
A cyclic octapeptide that activates MC4R downstream of a broken pathway. A short physician’s read on the biology, the data and who to test.
Maridebart Cafraglutide: A Physician’s Read on a Monthly GLP-1 Antibody-Peptide Conjugate
A GLP-1 agonist carried by a GIP receptor blocking antibody, dosed every 4 to 8 weeks. A short physician’s read on the design, the data and the open questions.
Orforglipron: A Physician’s Read on the First Small Molecule GLP-1 Medicine
The first GLP-1 receptor agonist that is not a peptide. A short physician’s read on the structure, the trials and the trade-offs.
Amylin, the Second Beta Cell Hormone: A Physician’s Read on Cagrilintide, CagriSema and REDEFINE
The beta cell ships two hormones at once. A short physician's read on amylin agonism and what the REDEFINE trials show.
The Counterintuitive Third Agonist: A Physician's Read on Glucagon, Retatrutide and TRIUMPH
Adding a hyperglycemic hormone to an incretin sounds wrong. A short physician's read on why it works, and what remains unknown.
A Lizard, One Amino Acid and a Self-Paid Patent: A Physician’s Read on Exendin-4
The first GLP-1 medicine came from a lizard and a doctor who paid for his own patent. Here is the short physician's read: one amino acid, four hours, and the honest trade-offs.
GLP-1 Was Hiding in Plain Sight: A Physician's Read on Its Discovery
I talk about GLP-1 with patients every week. Almost nobody knows it was found in a fish gene, by a chemist who saw 31 where others saw 37. Here is the short physician's read.
Recombinant Human Insulin, 1972 to 1982: A Physician’s Read on Boyer, Cohen and Genentech
The 1973 plasmid paper, somatostatin expressed in E. coli in 1977, the two-chain insulin method of 1978, and the 1982 FDA approval, read as a physician, with what it means for how medicines are made.
The Hypothalamic Hormones, 1969 to 1977: A Physician’s Read on Guillemin, Schally and Yalow
TRH, GnRH and somatostatin read as a physician: what the 1969 to 1973 papers showed, the 1978 pulsatility finding behind GnRH agonists, why somatostatin was redesigned as octreotide, and Yalow’s radioimmunoassay.
1902, Secretin and Fischer: A Physician’s Read on the Birth of Peptide Science
How a denervated loop of gut and a Berlin flask launched peptide science in 1902: the experiment, the 68-year path to secretin’s sequence, the limits, and why it still matters for GLP-1 therapy.